Related Experiment Video
Updated: Apr 15, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
Programmed cell death in aging
1Molecular and Computational Biology Program, Department of Biological Sciences, University of Southern California, 1050 Childs Way, RRI 201, Los Angeles, CA 90089-2910, USA.
Abstract:
Programmed cell death (PCD) pathways, including apoptosis and regulated necrosis, are required for normal cell turnover and tissue homeostasis. Mis-regulation of PCD is increasingly implicated in aging and aging-related disease. During aging the cell turnover rate declines for several highly-mitotic tissues. Aging-associated disruptions in systemic and inter-cell signaling combined with cell-autonomous damage and mitochondrial malfunction result in increased PCD in some cell types, and decreased PCD in other cell types. Increased PCD during aging is implicated in immune system decline, skeletal muscle wasting (sarcopenia), loss of cells in the heart, and neurodegenerative disease. In contrast, cancer cells and senescent cells are resistant to PCD, enabling them to increase in abundance during aging. PCD pathways limit life span in fungi, but whether PCD pathways normally limit adult metazoan life span is not yet clear. PCD is regulated by a balance of negative and positive factors, including the mitochondria, which are particularly subject to aging-associated malfunction.
Insights
Programmed cell death (PCD) pathways are crucial for tissue health but become dysregulated during aging. This imbalance contributes to age-related diseases and affects cell turnover, impacting longevity.
Area of Science:
- Cell Biology
- Aging Research
- Physiology
Background:
- Programmed cell death (PCD) pathways, encompassing apoptosis and regulated necrosis, are vital for cellular turnover and maintaining tissue homeostasis.
- Dysregulation of PCD is increasingly linked to the aging process and age-related diseases.
- Aging is characterized by declining cell turnover in highly proliferative tissues.
Purpose of the Study:
- To explore the role of programmed cell death (PCD) in aging.
- To understand how aging-associated disruptions impact PCD pathways.
- To investigate the implications of altered PCD in age-related conditions.
Main Methods:
- Review of existing literature on PCD and aging.
- Analysis of cellular and systemic signaling changes during aging.
- Examination of mitochondrial function in relation to PCD.
Main Results:
- Aging leads to altered PCD rates, with increased rates in some cells and decreased rates in others.
- Increased PCD contributes to immune decline, sarcopenia, cardiac cell loss, and neurodegeneration.
- Cancer and senescent cells exhibit resistance to PCD, promoting their accumulation with age.
Conclusions:
- Mitochondrial malfunction and signaling disruptions are key factors in aging-associated PCD dysregulation.
- Altered PCD pathways have significant implications for age-related pathologies and tissue function.
- The precise role of PCD in limiting adult metazoan lifespan requires further investigation.
More Related Videos
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Replicative Cell Senescence
Replicative Cell Senescence
The Intrinsic Apoptotic Pathway

